Rhythm Pharmaceuticals, Inc. RYTM Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Rhythm Pharmaceuticals, Inc.’s reported figures.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s enterprise value?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported enterprise value of $5.99B in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s enterprise value changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s enterprise value increased by 78.4% year-over-year, from $3.36B to $5.99B.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s enterprise value has grown at a 38.8% compound annual growth rate (CAGR), from $1.4B to $7.2B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.